Fortem Financial Group’s iBio IBIO Stock Holding History

Fortem Financial Group’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11	Closed	-$6K	–	288
2020 Q4	$6K	Buy	+11	New	+$8.96K	﹤0.01%	382

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fortem Financial Group's IBIO Position: Q1 2021 in Review

Fortem Financial Group sold out of iBio (IBIO) in Q1 2021, closing a stake of 11 shares — an estimated $6K sold.

Fortem Financial Group first reported a position in IBIO in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 91 funds tracked by Wall St. Rank hold IBIO as of Q1 2021.

Fortem Financial Group reported no remaining iBio position as of Q1 2021 after selling out during the quarter.
Fortem Financial Group sold 11 iBio shares in Q1 2021, an estimated $6K.
Fortem Financial Group first reported a position in iBio in Q4 2020 and held it in 1 quarter.
Fortem Financial Group's iBio position peaked at $6K in Q4 2020.
91 funds tracked by Wall St. Rank held iBio as of Q1 2021.

Based on Fortem Financial Group's 13F filing for Q1 2021, filed 20 Apr 2021.